About Recombinant Human Erythropo Injection
Recombinant Human Erythropo Injection is a high-quality therapeutic solution designed to address anemia associated with conditions such as chronic kidney disease. Each dose contains 4000 IU of Recombinant Human Erythropoietin, formulated in liquid form for precise and easy administration. This injection is specifically suitable for adult patients and is delivered in a compact vial for convenient usage. It works by stimulating the production of red blood cells, enhancing oxygen delivery across the body. To ensure safety and efficacy, the injection should be stored at room temperature in a secure location. With its reliable composition and trusted performance, this product is an essential offering for hospitals, clinics, and healthcare providers.
FAQs of Recombinant Human Erythropo Injection:
Q: What is the recommended dosage of Recombinant Human Erythropo Injection?
A: The recommended dosage is 4000 IU per administration.
Q: Is this injection suitable for all age groups?
A: No, this injection is specifically suitable for adults.
Q: What is the physical form of this medication?
A: The injection is provided in liquid form for direct administration.
Q: What is the main salt composition of this injection?
A: It contains Recombinant Human Erythropoietin as its key active ingredient.
Q: How should this injection be stored?
A: It should be stored at room temperature in a secure and stable environment.